You are here: Industry Insights > anti-inflammatory

News List

Echinacea Extract: Therapeutic Potential and Traditional Uses David Orchard-Webb
November 05, 2024
Echinacea is known for its brilliant purple petals and cone-shaped core, has been used for generations for medicinal purposes.
Scientists to investigate arthritis drug as potential therapy for vascular dementia expresspharma
October 19, 2020
New funding by the British Heart Foundation awarded to the Universities of Sheffield and Manchester to investigate the link between heart disease and vascular dementia.
Noveome studies anti-inflammatory drug ST266 in Covid-19 pharmaceutical-technology
April 01, 2020
Next generation biologics company Noveome Biotherapeutics will evaluate its lead programme ST266 as a potential treatment of severe cytokine storm response associated with Covid-19.
New data show Symbicort reduces attacks in mild asthma when used as an anti-inflammatory reliever worldpharmanews
May 24, 2019
New data from Novel START, an open-label trial designed to reflect real-world practice, has demonstrated the effectiveness of Symbicort Turbuhaler (budesonide/formoterol) as a potential anti-inflammatory reliever in mild asthma.
Glucosamine Joint Pain Supplement Could Help the Heart drugs
May 15, 2019
Glucosamine Joint Pain Supplement Could Help the Heart.
Kineret reduces inflammation in stroke patients europeanpharmaceuticalreview
April 28, 2019
An anti-inflammatory drug given to patients in the early stages of a stroke has been shown to reduce harmful inflammation…
Anti-Inflammatory Add-On May Be Beneficial for Depression drugs
April 19, 2019
Anti-Inflammatory Add-On May Be Beneficial for Depression.
Novartis adds clinical and preclinical anti-inflammatory programs to portfolio with acquisition of IFM Tre worldpharmanews
April 04, 2019
Novartis announced that it is adding to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre
Pfizer secures Humira licence agreements with AbbVie pharmaceutical-technology
December 04, 2018
Pfizer has resolved licensing issues regarding its adalimumab biosimilar that was deemed too close to AbbVie’s Humira (adalimumab).....
New study argues the importance of existing anti-inflammatory drugs in fighting dementia pharmafile
May 04, 2018
Research into dementia has waned in recent times as researchers struggle to pin down concrete advancements, leading to the withdrawal of Pfizer from the space, among others.

Previous page 1 2 Next page